Time limits apply in New York. Find out if you still qualify.
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Verified against court and regulatory records · No upfront fees · Your information is never sold
Statute of limitations — New York
New York CPLR § 214(5) provides a 3-year statute of limitations for personal injury claims including pharmaceutical product liability. The discovery rule applies — the limitations period runs from the date the plaintiff discovered or reasonably should have discovered the vision injury and its connection to Elmiron. New York does not have a general statute of repose for product liability claims.
3 years from discovery of Elmiron-related vision injury
Filing venue
Where to File in New York
Federal Elmiron cases from New York are transferred to the MDL in the District of New Jersey (MDL No. 2973). New York state court claims may proceed in New York County (Manhattan), Kings County (Brooklyn), or other New York Supreme Court venues. New York applies a Frye standard for expert admissibility, which can be more permissive than the federal Daubert standard. The 3-year statute of limitations and absence of a product liability statute of repose make New York particularly favorable for patients who used Elmiron for many years before the retinal toxicity link was publicized.
New York data
Exposure in New York
New York population — fourth-largest state with dense concentration of urology and ophthalmology specialists, particularly in the NYC metropolitan area
19.6 million
Source: U.S. Census Bureau 2024
New York's statute of limitations for pharmaceutical injury claims — one year longer than most states, providing additional time for Elmiron claimants to identify and pursue claims
3 years
Source: CPLR § 214(5)
Approximate rate of pigmentary maculopathy found in patients who used Elmiron for more than 15 years in published ophthalmology studies
25%
Source: JAMA Ophthalmology
Keep reading